Jeffrey (Jeff) W. Sherman, MD, FACP, is Chief Medical Officer and Executive Vice President at Horizon Therapeutics based in Lake Forest, Illinois. Jeff has more than 25 years of experience in the pharmaceutical industry at IDM Pharma, Takeda Global Research and Development, NeoPharm, Searle/Pharmacia, and Squibb/Bristol-Myers Squibb. He also serves on the Board of Directors of Strongbridge Biopharma and Xeris Pharmaceuticals. Jeff is an Adjunct Assistant Professor of Medicine at the Northwestern University Feinberg School of Medicine. Jeff also serves on the Rosalind Franklin University of Medicine and Science College of Pharmacy Advisory Board. Jeff is a Past Board Chairperson and Board Member of the Drug Information Association (DIA), and an inaugural fellow. Jeff in addition serves on the Board of Advisors of the Center for Information and Study on Clinical Research Participation (CISCRP). He is also a member of the Global Genes Medical and Scientific Advisory Board and involved with the National Organization for Rare Disorders (NORD).